AstraZeneca will conduct a study of a new drug against COVID-19 in the Russian Federation
[ad_1]
Despite statements by international pharmaceutical companies about the suspension of new trials in Russia after the outbreak of hostilities in Ukraine, the British-Swedish AstraZeneca plans to conduct a study in the Russian Federation of a new drug for the prevention of COVID-19, which is necessary before its registration.
As Kommersant clarifies, this is so far the only Western pharmaceutical manufacturer that has already twice received permission to conduct local trials of new drugs this year. Other Western companies are not trying to resume their activity in the Russian market, experts say.
[ad_2]
Source link
